Document is current
Any future updates will be listed below
-
Authors
Reesen, J. E.
van de Kamer, F. M.
van Keeken, A. E.
Ikelaar, S. L.C.
van Oppen, P.
Batelaan, N.
Lancee, J.
van Someren, E. J.W.
van Nassau, F.
-
Funding
Funding for this research was provided by:
Vrije Universiteit Amsterdam University Research Fellowship
Hersenstichting (DR-2019-00322, DR-2019-00345)
ZonMw Leefstijlgeneeskunde (555003203)
ZonMw Open Competition (09120011910032)
Health~Holland (LSHM19118-HSGF)
Wellcome Trust (UNS144029)
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 7 April 2025
First Online: 28 April 2025
Declarations
:
: This study is in accordance with the ethical standard of relevant national and international committees on human experimentation and the declaration of Helsinki. All participants provided written informed consent. The study protocol was approved by the Medical Ethics Committee of the VU University Medical Centre (METC VUmc, registration number 2021/093) and registered as a clinical trial on the Netherlands Trial Register (NL9776) with the registration date of 07/10/2021.
: Not applicable.
: The authors declare the following financial interests/personal relationships that could be considered potential competing interests: JL is one of the developers of the i-Sleep intervention but holds no commercial or financial interests in it. JR, AVK, and SI participated as therapists in the study. While AVK co-held the focus groups, she was not providing participant guidance at that time. All other authors declare that they have no known financial interests or personal relationships that could have influenced the work reported in this paper.
